SECTION I: Movement Disorders (Joel Perlmutter, Washington University) 1. History of ParkinsonismMichael Silver, MD and Stewart A. Factor, DO2. Parkinson Disease: Pathophysiology, Clinical Manifestations and Course including Diagnosis and Differential Diagnosis Michael J. Soileau, MD and Kelvin L. Chou, MD3. Parkinson Disease: Treatment, Current Clinical Trials Thien Thien Lim, MD and Hubert H. Fernandez, MD4.

Parkinson Syndromes: Multiple System Atrophy Melvin W. Kong, MD and Ejaz A. Shamim MD, MS5. Parkinson Syndromes: Progressive Supranuclear Palsy Vikas Kotagal, MD, MS and Praveen Dayalu, MD6. Parkinson Syndromes: Corticobasal Degeneration Sami Barmada, MD, PhD7. Huntington Disease: Etiology, Genetics, and Clinical Manifestations Roger L. Albin, MD and Henry L. Paulson, MD, PhD8.

Huntington Disease: Treatment, Current Clinical Trials Charles S. Venuto, PharmD and Karl Kieburtz, MD, MPH9. Essential Tremors Arif Dalvi, MD, MBA, Kelly E. Lyons, PhD, and Rajesh Pahwa, MD10. Dystonia: History and Classification H. A. Jinnah, MD, Cecilia N. Prudente, MD, Samuel J.

Rose, MD and Ellen J. Hess, MD11. Dystonia: Pathophysiology, Clinical Manifestations and Course Including Diagnosis, and Differential Diagnosis, Treatment, Current Clinical TrialsJeri Yvonne Williams, MD and David G. Standaert, MD, PhD12. Paroxysmal Dyskinesias Olga Waln, MD and Joseph Jankovic, MD.13. The Expanded Polyglutamine Tract Spinocerebellar AtaxiasElsdon Storey, MD14. Ataxias: Autosomal Recessive and other AtaxiasVikram G.

Shakkottai, MD, PhDSECTION II: Dementias (David Knopman, Mayo Clinic) 15. Alzheimer''s Disease: Pathology and Pathogenesis Bradley T Hyman, MD, Beatriz G Perez-Nievas, MD, Isabel Barroeta-Espar, MD, Alberto Serrano-Pozo, MD, Matthew Frosch, MD, and Teresa Gomez-Isla, MD16. Alzheimer''s Disease: Clinical Manifestations and Diagnostic/Differential DiagnosisMichael S. Rafii, MD, PhD17. Alzheimer''s Disease: Management and Treatment Gregory A. Jicha, MD, PhD and Frederick A. Schmitt, PhD18. Frontotemporal Degenerations Jonathan Graff-Radford, MD, and Keith A.

Josephs, MD, MST, MSc19. Diagnosis and Therapy for Lewy Body DementiaBela R. Turk, MD and Ali Fatemi, MD20. Pathogenesis of Lewy Body DementiaJagan A. Pillai, MD, PhD and James B. Leverenz, MD21. Cerebrovascular DementiaRahul Karamchandani, MD and Nancy R. Barbas, MD, MSWSECTION III: Motorneuron Diseases (Merit Cudkowicz, Massachusetts General Hospital, Harvard University) 22.

Types of MNDS Nimish Thakore, MD and Erik P. Pioro, MD, PhD23. Clinical Presentations, Diagnostic Criteria, Lab Testing Nimish Thakore, MD and Erik P. Pioro, MD, PhD24. Symptomatic Care Matthew Gladman, MD and Lorne Zinman, MD, MSc25. ALS: Epidemiology Éilis J. O''Reilly, ScD26. ALS: Pathogenesis Laura Ferraiuolo, MD and Stephen J.

Kolb, MD27. ALS: Insights from Genetics Matthew B. Harms, MD and Timothy M. Miller, MD, PhD28. ALS: In Vitro and In Vivo Disease Models Brian J. Wainger, MD, PhD29. ALS Pathology Brent T. Harris, MD, PhD, Galam A.

Khan, MD, and Saed Sadeghi, MD 30. ALS: Clinical Trials Past Reflections Informing New DirectionsKatharine A. Nicholson, MD and James D. Berry, MD 31. Upper Motor Neuron Disorders: Hereditary Spastic Paraplegia and Primary Lateral SclerosisJohn K. Fink, MD 32. UMN Disorders (HSP and PLS): Pathogenesis, Insights from Genetics, In Vitro and In Vivo Disease Models, Pathology and Clinical Trials Sabrina Paganoni, MD, PhD and Nazem Atassi, MD, MMSc33. SMA: Pathogenesis Umrao R.

Monani, PhD and Darryl C. De Vivo, MD34. SMA: Insights from GeneticsArthur H.M. Burghes, MD and Vicki L. McGovern, MD 35. SMA: In Vitro and In Vivo Models of Spinal Muscular AtrophyW. David Arnold, MD and Arthur H.

M. Burghes, MDSECTION IV: Paroxysmal Disorders (Solomon Moshe, Albert Einstein College of Medicine) 36. Biological Basis of Primary Generalized Epilepsies-GeneticsCarla Marini, MD and Renzo Guerrini, MD37. Biological Basis of Primary Generalized Epilepsies - PathophysiologyMark W. Youngblood, MD and Hal Blumenfeld, MD38. Temporal Lobe EpilepsyEdward H. Bertram, MD39. Focal Cortical DysplasiasAli Mahta, MD and Peter B.

Crino, MD, PhD40. Biological Bases of Symptomatic Generalized Epilepsies in ChildrenDragos A. Nita, MD, Miguel A. Cortez, MD, Jose Luis Perez Velazquez, MD, and O. Carter Snead 3rd, MD41. Epilepsies that Occur Predominantly in Girls Lynette G Sadleir, MD, Jozef Gecz, MD, and Ingrid E Scheffer, MD42. Epidemiology of Epilepsy: Incidence, Prevalence, and Risk FactorsDale C Hesdorffer, PhD, MPH43. Clinical Presentation, Diagnosis, and Course- Epilepsy Syndromes with Focal SeizuresAlex Boro, MD and Jerome Engel, Jr.

, MD44. Medical Management of EpilepsyJules C. Beal, MD and Emilio Perucca, MD45. Neuroimaging in Epilepsy William A. Gomes, MD, PhD47. Alternative Therapies for Epilepsy: Dietary TreatmentsCarl E. Stafstrom, MD, PhD48. Migraine and Other Headache Disorders Robert W.

Charlson, MD and Matthew S. Robbins, MD49. Neurobiology of MigraineVictor Rosenfeld, MD and John Stern, MDSECTION V: Pediatric Neurology and Developmental Disorders (Tanjala Gipson and Deepa Menon, Kennedy Krieger Institute and Johns Hopkins University) 50. Autism and Intellectual Disabilities: Overview of Autism and Intellectual DisabilitiesTanjala T. Gipson, MD and Michael V. Johnston, MD51. Tuberous Sclerosis Complex: Pediatric AspectsTanjala T. Gipson, MD, Andrea Poretti, MD, Rebecca McClellan, MGC, CGC, and Michael V.

Johnston, MD52. Neurofibromatosis Type 1David S. Wolf, MD, PhD53. Neurobiology of Autism and Intellectual Disability: Fragile X SyndromeDejan B. Budimirovic, MD and Megha Subramanian, BA54. Autism and Intellectual Disabilities: PTEN Gene mutation Deepa U. Menon, MBBS, MD55. Rett SyndromeC.

L. Smith-Hicks, MD and SakkuBai Naidu, MD56. Angelman Syndrome Kristin W. Barañano, MD, PhD57. Down SyndromeGeorge T. Capone, MD58. Coffin-Lowry SyndromeMichael V. Johnston, MD59.

Congenital HypothyroidismMary Lee Gregory, MD, PhD60. Pediatric Neurotransmitter DisordersPhillip L. Pearl, MD and William P. Welch, MD61. Attention Deficit-Hyperactivity DisorderMihee J. Bay, MD and Bruce K. Shapiro, MD62. Diseases of Mitochondrial Energy MetabolismJacqueline Weissman, MD, MS and Lisa Emrick, MD63.

Genetic Metabolic Disorders: MethylmalonicAciduria Siddharth Srivastava, MD and Jeffrey Chinsky, MD PhD64. The Urea Cycle DisordersAndrea L. Gropman, MD, Belen Pappa, MD, and Nicholas Ah Mew, MD65. Phenylketonuria Hilary Vernon, MD, PhD66. Cerebral Creatine Deficiency DisordersPeter W. Schutz, MD and Sylvia Stockler, MD67. Congenial Disorders of GlycosylationMarc C. Patterson, MD, FRACP68.

Glutaric Aciduria Type IHilary Vernon, MD, PhD69. Lysosomal Storage Disroders Gustavo H.B. Maegawa, MD, PhD, FACMG70. Peroxisomal DisordersGerald V. Raymond, MD, Mohamed Y. Jefri, MD, Kristin W. Baranano, MD, and Ali Fatemi, MD 71.

Leukodystrophies Ulrike Schrifl, MD, SakkuBai Naidu, MD, and Ali Fatemi, MD72. Cerebral PalsyJoan M. Jasien, MD, Bruce K. Shapiro, MD and Alexander H. Hoon, Jr., MD73. Neonatal Brain InjuriesKatharina Goeral, MD, Ali Fatemi, MD, and Michael V. Johnston, MD74.

The Neurobiology of Encephalopathy of PrematurityGwendolyn J. Gerner, MD and Vera Joanna Burton, MD75. Epilepsy Syndromes in ChildhoodVerena Staedtke, MD and Eric H. Kossoff, MD76. Migraine and Headaches in Children Jessica Klein, MD and Christopher Oakley, MD77. Congenital Hydrocephalus Vera Joanna Burton, MD and Edward Ahn, MD78. Spina Bifida and Related ConditionsStephen L. Kinsman, MD79.

Smith-Lemli-Opitz SyndromeRyan W. Lee, MD80. Sickle Cell AnemiaEboni I. Lance, MDSECTION VI: Neuroimmunological Diseases (Carlos Pardo-Villamizar, Johns Hopkins University) 81. The Epidemiology of Multiple Sclerosis: An Historical PerspectiveKassandra L. Munger, ScD82. Multiple Sclerosis: PathologyBogdan Florin Gh. Popescu, MD, Yong Guo, MD, and Claudia Francesca Lucchinetti, MD83.

Multiple Sclerosis: MRI and Other Imaging Approaches in MS Martina Absinta, MD and Daniel S. Reich, MD, PhD84. Multiple Sclerosis: White Matter vs Grey Matter Involvment (The Cause of Disability in MS)Massimo Filippi, MD, and Maria A. Rocca, MD.85. Multiple Sclerosis: Monitoring disease activity and progressionPavan Bhargava, MD and Shiv Saidha, MBBCh, MD, MRCPI86. Symptomatic Treatment of Multiple SclerosisKathleen Costello, RN, BSN, MS87. Exercise and Multiple SclerosisJeffrey R Hebert, PT, PhD88.

Multiple Sclerosis: Disease Modifying TherapiesPavan Bhargava, MD and Peter A. Calabresi, MD89. Neuromyelitis OpticaTeri L. Schreiner, MD, MPH and Jeffrey L. Bennett, MD, PhD 90. Acute Disseminated Encephalomyelitis Benjamin M. Greenberg, MD, MHS and Allen Desena, MD93. Paraneoplastic Neurological DisordersJohn C.

Probasco, MD94. Anti-N-Methyl-D-Aspartate Receptor (NMDAR) EncephalitisElizabeth M. Wells, MD, MHS95. Other Proven and Putative Autoimmune Disorders of the CNS: Anti-GAD Associated Neurological Disorders; Stiff-Person syndrome, Cerebellar Ataxia, Progressive Encephalopathy with Rigidity and Myoclonus (PERM), and Encephalitis. Scott D. Newsome, DO96. Other Proven and Putative Autoimmune Disorders of the CNS: Hashimoto''s EncephalopathyEoin P. Flanagan, MBBCh and Richard J.

Caselli, MD97. Other Proven and Putative Autoimmune Disorders of the CNS: Neuro-Bechet''s Syndrome Afshin Borhani Haghighi M.D and Bernadette Kalman, MD, PhD, DSc98. Post-Streptococcal Movement DisordersDavide Martino, MD and Gavin Giovannoni, MD99. Rasmussen EncephalitisJan Bauer, MD and Christian G. Bien, MD100. Autoimmune EncephalitisAndrew McKeon, MD101. Other Proven and Putative Autoimmune Disorders of the PNS: Myasthenia gravisDoris G.

Leung, MD102. Vasculitis of the central nervous systemChristian Pagnoux, MD and Richard H. Swartz, MDSECTION VII: Cerebrovascular Diseases (Harold Adams, University of Iowa) 103. Stroke Epidemiology and Impact: Mortality, Incidence, Prevalence, Stroke Subtypes, Sex, Race/Ethnicity, Geography U.S. and WorldVirginia J Howard, PhD104. Acute Ischemic StrokeHarold P. Adam.